MetLife Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

MetLife Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-37,639	Closed	-$677K	–	2359
2020 Q2	$677K	Buy	37,639 +4,664	+14%	+$64.9K	0.01%	1215
2020 Q1	$235K	Hold	32,975	–	–	﹤0.01%	1604
2019 Q4	$787K	Hold	32,975	–	–	0.01%	1218
2019 Q3	$884K	Buy	32,975 +3,043	+10%	+$85.4K	0.01%	1131
2019 Q2	$812K	Hold	29,932	–	–	0.01%	1212
2019 Q1	$1.04M	Hold	29,932	–	–	0.01%	1066
2018 Q4	$584K	Hold	29,932	–	–	0.01%	1270
2018 Q3	$797K	Hold	29,932	–	–	0.01%	1245
2018 Q2	$1.13M	Buy	29,932 +4,318	+17%	+$165K	0.01%	974
2018 Q1	$837K	Hold	25,614	–	–	0.01%	1086
2017 Q4	$1.25M	Buy	+25,614	New	+$1.3M	0.01%	944

MetLife Investment Management's PTLA Position: Q3 2020 in Review

MetLife Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 37,639 shares — an estimated $677K sold.

MetLife Investment Management first reported a position in PTLA in Q4 2017 and held it in 11 quarters. The position peaked at $1.25M in Q4 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

MetLife Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
MetLife Investment Management sold 37,639 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $677K.
MetLife Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2017 and held it in 11 quarters.
MetLife Investment Management's Portola Pharmaceuticals, Inc. position peaked at $1.25M in Q4 2017.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.